Paulson & Co. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$1,807,000
-0.8%
662,056
+20.4%
0.02%0.0%
Q1 2017$1,821,000
+97.3%
550,000
+41.9%
0.02%
+100.0%
Q4 2016$923,000
-68.8%
387,697
-51.8%
0.01%
-62.5%
Q3 2016$2,954,000
+32.5%
805,000
-19.5%
0.03%
+39.1%
Q2 2016$2,229,000
+7.2%
999,7000.0%0.02%
+53.3%
Q1 2016$2,079,000
+29.8%
999,700
+89.1%
0.02%
+50.0%
Q4 2015$1,602,000528,7000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
UBS OCONNOR LLC 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders